Clinical Trial Update: Multimodality Treatment in Stage III Non-small Cell Lung Cancer (NSCLC) [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 multimodality treatment study for stage III non-small cell lung cancer, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Non-small Cell Lung Cancer, NSCLC | Phase 2 | Status: ACTIVE_NOT_RECRUITING